Skip to main content

Advanced Biomed Inc.

corporate_fare Company Profile

Advanced Biomed Inc.

ADVB·NASDAQ·Industrial Applications And Services·CIK 0001941029

Advanced Biomed Inc. is a holding company incorporated in the State of Nevada that develops and operates an enterprise AI financial verification platform. In April 2026, Advanced Biomed Inc. acquired 100% of the equity interests of Acellent Technologies (Hong Kong) Co. Limited ("Acellent"). Acellent develops and operates the FinTruth Financial Verification Agent Platform ("FinTruth"), which is designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, producing source-traceable and auditable results. In December 2025 and June 2026, Advanced Biomed Inc. sold Advanced Biomed HK (together with its subsidiary, Shanghai Sglcell) and Advanced Biomed Taiwan, respectively. These transactions disposed of the company's biomedical operations, and Advanced Biomed Inc. has since fully shifted its focus towards developing its AI application through FinTruth. Prior to this shift, Advanced Biomed Inc. focused on developing lab devices and chemicals for finding and studying cancer cells in a patient's blood, with the goal of helping doctors detect and monitor cancer through blood tests. Its products included A+Pre, a device for preparing blood samples; the AC-1000, a device for separating cancer cells; the A+SCDrop, a device for isolating individual cells; and the A+CellScan, a device for staining and automatically counting cancer cells. The company also developed dye kits for identifying different types of cancer cells. The A+Pre and AC-1000 devices were the only products not awaiting regulatory approval from the PRC government. As of the date of this Report, Advanced Biomed Inc. has terminated its biomedical business and stopped all research, product development, regulatory approval efforts, manufacturing, and sales activities related to its lab devices, operating chips, and lab chemicals for cancer research.

Advanced Biomed Inc. (NASDAQ:ADVB) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 22 items for ADVB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ADVB spans 8-K, 10-Q, 10-K, DEF 14A.

Recent high-impact activity:

  • Advanced Biomed Raises $112,000 in Private Placement at $0.35 per Share
  • Advanced Biomed Q1 Loss Widens to $989K; Cash Down to $214K After $613K Credit Charge
  • Advanced Biomed 10-K Reveals Material Weaknesses, $2.9M Credit Loss Provision, and $14M Divestiture Gain
  • $25M Equity Purchase Pact Terminated, Removing Potential Dilution Overhang
  • Advanced Biomed Ends $25M Equity Line with Helena Global, Having Sold No Shares

Financial Snapshot

Fiscal year ended June 30, 2026
Revenue
127.64K
Net Income
6.68M
Diluted EPS
5.33
Op. Cash Flow
-1.95M
Operating Income
-6.23M
Cash & Equivalents
385.54K
Debt / Equity
0.00×
Net Margin
52.31×
Shares Outstanding
1.65M sh
Source: 10-K · filed 2026-10-13 · accession 0001213900-26-109029

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 11,238 shares in ADVB as of the October 30, 2026 settlement, a 15.3% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 33.0% of ADVB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)11,238 shares as of October 30, 2026
Change vs prior period▲ 15.3%
Days to cover1.00 at avg daily volume of 56,323
Daily short volume (FINRA facilities)33.0% of 7,590 shares on November 20, 2026
5-day average short volume40.4%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with A →
$1.67 +1.45% today
52-week range · as of 2026-11-20 $1.58 – $24.23
Market cap
$2.73M
Volume
16.7K (0.2× avg)
3-mo avg 68K
Live data · 2026-11-21 20:20 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ADVB - Latest Insights

ADVB
Nov 20, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.67 info
Change: +$0.0239 (+1%) info
Market Cap: $2.726M info
ADVB
Nov 12, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.38
Real-time Price: $1.67 info
Change: -$1.71 (-50%) info
Market Cap: $2.726M info
ADVB
Oct 13, 2026, 4:16 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $5.18
Real-time Price: $1.67 info
Change: -$3.51 (-68%) info
Market Cap: $2.726M info
ADVB
Jul 17, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $5.46
Real-time Price: $1.67 info
Change: -$3.79 (-69%) info
Market Cap: $2.726M info
ADVB
Jul 17, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.03
Real-time Price: $1.67 info
Change: -$3.36 (-67%) info
Market Cap: $2.726M info
ADVB
Jun 30, 2026, 4:34 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.70
Real-time Price: $1.67 info
Change: -$3.03 (-64%) info
Market Cap: $2.726M info
ADVB
Jun 04, 2026, 7:30 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $4.60
Real-time Price: $1.67 info
Change: -$2.93 (-64%) info
Market Cap: $2.726M info
ADVB
May 15, 2026, 9:28 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $4.39
Real-time Price: $1.67 info
Change: -$2.72 (-62%) info
Market Cap: $2.726M info
ADVB
May 01, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $8.30
Real-time Price: $1.67 info
Change: -$6.63 (-80%) info
Market Cap: $2.726M info
ADVB
Apr 14, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.31
Real-time Price: $1.67 info
Change: -$4.64 (-73%) info
Market Cap: $2.726M info
ADVB
Apr 03, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $4.55
Real-time Price: $1.67 info
Change: -$2.88 (-63%) info
Market Cap: $2.726M info
ADVB
Apr 03, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.55
Real-time Price: $1.67 info
Change: -$2.88 (-63%) info
Market Cap: $2.726M info
ADVB
Mar 30, 2026, 5:32 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.40
Real-time Price: $1.67 info
Change: -$2.73 (-62%) info
Market Cap: $2.726M info
ADVB
Mar 16, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.43
Real-time Price: $1.67 info
Change: -$3.76 (-69%) info
Market Cap: $2.726M info
ADVB
Feb 26, 2026, 4:31 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.97
Real-time Price: $1.67 info
Change: -$2.30 (-58%) info
Market Cap: $2.726M info
ADVB
Feb 13, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.2401
Real-time Price: $1.67 info
Change: Reverse Stock Split info
Market Cap: $2.726M info
ADVB
Feb 10, 2026, 4:00 PM EST
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $0.245
Real-time Price: $1.67 info
Change: Reverse Stock Split info
Market Cap: $2.726M info
ADVB
Feb 02, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.283899
Real-time Price: $1.67 info
Change: Reverse Stock Split info
Market Cap: $2.726M info
ADVB
Jan 27, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.3011
Real-time Price: $1.67 info
Change: Reverse Stock Split info
Market Cap: $2.726M info
ADVB
Jan 23, 2026, 4:00 PM EST
Filing Type: DEF 14C
Importance Score:
8
Price at Filing: $0.3192
Real-time Price: $1.67 info
Change: Reverse Stock Split info
Market Cap: $2.726M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets